Multiorgan Dysfunction Caused by Travel-associated African Trypanosomiasis

We describe a case of multiorgan dysfunction secondary to Trypanosoma brucei rhodesiense infection acquired on safari in Zambia. This case was one of several recently reported to ProMED-mail in persons who had traveled to this region. Trypanosomiasis remains rare in travelers but should be considered in febrile patients who have returned from trypanosomiasis-endemic areas of Africa.

[1]  Drugs for parasitic infections. , 2015, The Medical letter on drugs and therapeutics.

[2]  C. Burri.  Chemotherapy against human African trypanosomiasis: Is there a road to success? , 2010, Parasitology.

[3]  B. Vanhollebeke,et al.  Human innate immunity against African trypanosomes. , 2009, Current opinion in immunology.

[4]  D. Freedman,et al.  Imported human African trypanosomiasis in Europe, 2005-2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  J. Rodgers.  Human African trypanosomiasis, chemotherapy and CNS disease , 2009, Journal of Neuroimmunology.

[6]  P. Kennedy.  The continuing problem of human African trypanosomiasis (sleeping sickness) , 2008, Annals of neurology.

[7]  B. Vanhollebeke,et al.  Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. , 2006, The New England journal of medicine.

[8]  R. Brasseur,et al.  Apolipoprotein L-I is the trypanosome lytic factor of human serum , 2003, Nature.

[9]  E. Fèvre,et al.  Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene , 2001, The Lancet.

[10]  J. Maguire,et al.  African trypanosomiasis in two travelers from the United States. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Baker.  Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. , 1999, World Health Organization technical report series.

[12]  G. Chrousos,et al.  Neuroendocrine Dysfunction in African Trypanosomiasis: The Role of Cytokines a , 1998, Annals of the New York Academy of Sciences.

[13]  M. A. Ogryzlo.  "The Medical Letter on Drugs and Therapeutics". , 1961, Canadian Medical Association journal.